Blended learning for entrepreneurial biomedical professionals

Paul Janssen Futurelab Leiden is an international blended learning (online and on-campus) program for entrepreneurial biomedical professionals.

profile of Scholarships for start-ups

Janssen Pharmaceutica offers scholarships for biomedical start-ups 

Read more

profile of CD online March 25

The next course Clinical Development starts on March 25, 2019

Learn more

On campus

Experience the on-campus

For four days, you will further explore question-based development in the beautiful setting of the castle and hotel Oud-Poelgeest. With a small group of maximum 30 course participants, you will reside at the castle and examine teaching cases that are based on real events. In “what really happened” sessions, invited speakers discuss the actual choices that were made during the case.


Read more

A selection of our contributors

On-campus

Tine de Marez

Tine de Marez

Senior Director, Compound Development Team Leader TB
Johnson & Johnson

Bert Leufkens

Bert Leufkens

Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board
Utrecht Institute for Pharmaceutical Sciences (UIPS)

Henk Schuring

Henk Schuring

VP-Head Rare Nephrology
Sanofi Genzyme

Sjaak Bot

Sjaak Bot

VP, Head of EMEA Regulatory Affairs
Janssen

Bernd van der Meulen

Bernd van der Meulen

Professor of Comparative Food Law
European Institute for Food Law / Renmin University of China Law School

Frank Landolt

Frank Landolt

V.P. intellectual property and legal
Ablynx N.V.

On-campus

Erik Niks

Erik Niks

Neurologist - Pediatric neurologist
Leiden University Medical Center

On-campus

Piet Hinoul

Piet Hinoul

Global Head, Pre-Clinical, Clinical and Medical Affairs
J&J Ethicon

On-campus

Ad Sitsen

Ad Sitsen

Owner
ClinPharMed Consultancy for Drug Development

Eline Bunnik

Eline Bunnik

Assistant professor Medical Ethics and Philosophy of Medicine
Erasmus MC

Maurits Westerik

Maurits Westerik

Senior Counsel
Bird & Bird

Andrea Kamage

Andrea Kamage

Patent Group Leader
Johnson & Johnson

Bart Swinkels

Bart Swinkels

Partner
NLO

Karin Verzijden

Karin Verzijden

Food and Pharma Lawyer
Axon Lawyers

On-campus

Ineke Jonker-Hoogerkamp

Ineke Jonker-Hoogerkamp

Consultant Regulatory Affairs and Drug Development
Paul Janssen Futurelab & Eagle Pharma Consult

Kees Recourt

Kees Recourt

Investment Manager
Mibiton Foundation

Paul Stoffels

Paul Stoffels

Chief scientific officer
Johnson & Johnson

Tom Huizinga

Tom Huizinga

Head of the Department of Rheumatology
Leiden University Medical Centre

On-campus

Marcel Kenter

Marcel Kenter

Director
Paul Janssen Futurelab Leiden

On-campus

Koen Andries

Koen Andries

VP Scientific Fellow Infectious Diseases Discovery
Janssen Pharmaceutica NV

On-campus

Andreas Wallnöfer

Andreas Wallnöfer

General Partner
BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)

On-campus

Justin Hay

Justin Hay

Pharmacokinetics Assessor
Medicines and Healthcare products Regulatory Agency

On-campus

André Elferink

André Elferink

Clinical epidemiologist
Dutch Medicines Evaluation Board

On-campus

Rob Zuiker

Rob Zuiker

Senior Clinical Scientist
CHDR

On-campus

Barbara J. van Zwieten-Boot

Barbara J. van Zwieten-Boot

Vice Chair
Medicines Evaluation Board, The Netherlands

Hans-Georg Eichler

Hans-Georg Eichler

Senior Medical Officer
European Medicines Agency

On-campus

Robert Klautz

Robert Klautz

Thoracic Surgeon
Leiden University Medical Centre

On-campus

Matthijs Moerland

Matthijs Moerland

Research Director Translational Biomarkers
CHDR

Joris Rotmans, MD, PhD

Joris Rotmans, MD, PhD

internist-nephrologist
LUMC

On-campus

Janneke Meulenberg

Janneke Meulenberg

CEO
Arthrogen

Inge de Lepeleire

Inge de Lepeleire

Director Translational Pharmacology
MSD Europe

On-campus

Koos Burggraaf

Koos Burggraaf

Research Director CVS & Metabolism
CHDR

Johan Garssen

Johan Garssen

Director Immunology Platform
Danone/Nutricia Research

On-campus

Ingrid de Visser

Ingrid de Visser

Senior Clinical Scientist
CHDR

Rick Kuntz

Rick Kuntz

Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Medtronic

On-campus

Geert Jan Groeneveld

Geert Jan Groeneveld

Research Director CNS
CHDR

Oliver Bisazza

Oliver Bisazza

Director Regulatory Policy
Medtronic

Saco de Visser

Saco de Visser

Head of Education and Clinical Pharmacologist
Paul Janssen Futurelab Leiden

On-campus

Adam Cohen

Adam Cohen

CEO and clinical pharmacologist
Centre for Human Drug Research

Richard Shull

Richard Shull

Head of Deal Structuring and Trading Fundamentals
Shell

Pierre Peeters

Pierre Peeters

Former site head early stage development
Organon

Our approach in professional learning

We offer a unique blend of online education and on-campus training for talented biomedical scientist that have the ambition to become the future generation Chief Scientific Officers.

Stay connected

Quote Paul Janssen Futurelab

A world of knowledge

"This training opened my eyes to a whole new world of knowledge on the development of medical interventions"

Willem Birkhoff, Centre for Human Drug Research, Clinical Development Online graduate

Quote Paul Janssen Futurelab

The mix worked well

"I was impressed with the versatility of the learning environment. The mix of texts, PDFs, videos, questions and assignments worked wonderfully well!"

Erik van Beers, Skyline DX, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Nicely set up

"I think this course is very nicely set up, with a mix of videos, explanations, examples and self-assessments"

Nicoline Treijtel, Astellas, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Excellent learning opportunities

“The cases were excellent and the manner in which they were presented provided excellent learning opportunities”

Vickas Patel, GlaxoSmithKline, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Not the traditional classroom

"Clinical development was dissected in a different way than I am used to, which was intriguing. The interface of the online course and exam were really nice: simple and straightforward to interact with, at your own pace and time, and you can go back and forth as you wish, certainly not the traditional way of a frontal classroom interface!”

Ofer Spiegelstein, Teva Pharmaceutical Industries Ltd, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Out of my comfort zone

“I loved the ‘corporate finance’ bit, really out of my comfort zone, but it did give me so much more insight into the financial considerations in clinical development”

Meta Roestenberg, Leiden University Medical Center, Clinical Development Online graduate

Recent tweets

Twitter image

Featured in Bionews: What can you expect from the Clinical Development course? #SpoilerAlert! https://t.co/LOa24wHQxc

Twitter imageTwitter image

Thank you #LIMSC for a nice Leiden International (Bio)Medical Student Conference. The atmosphere was relaxed and buzzing! @LustrumMFLS https://t.co/rcCRSxjDxi

Twitter image

The Janssen scholarship is now closed and applications are being reviewed as we speak. Candidates from Dutch UMCs and NKI/AVL can still apply for a scholarship until March 11! https://t.co/EHfBr9xdQU https://t.co/EHfBr9xdQU

RT @PivotPark: Meet us next Thursday at Innovation for Health! Learn about the latest developments in the field of #immunology during our m…